Literature DB >> 352940

Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.

J E Domer, S A Moser.   

Abstract

Attempts were made to isolate an antigen(s) from Candida albicans suitable for detecting hypersensitivity in a murine model of candidiasis. Using footpad reactivity in cutaneously infected animals as the assay, comparisons were made of two commercial extracts and cell wall and cytoplasmic preparations made in the laboratory. An extract of the cell wall, a glycoprotein (GP) removed with ethylenediamine, and an extract prepared from the membrane fraction of disrupted C. albicans blastospores proved most useful in demonstrating delayed hypersensitivity in the murine model. The activity of the GP fraction was considerably reduced by oxidation with periodate and was abrogated entirely by digestion with proteolytic enzymes. The extract from the membrane fraction was obtained by incubating the insoluble membrane fraction with phosphate-buffered saline, pH 7.4, at 50 degrees C, and the proteins in the extract were subsequently precipitated with ammonium sulfate to yield a test preparation that was approximately 75% protein and 25% carbohydrate. The precipitated extract was designated ppt-HEX. Footpad reactivity to ppt-HEX could be transferred with cells and not with serum if the cells were taken from animals at the appropriate time after sensitization. Since the membrane and GP fractions appear to elicit true delayed hypersensitivity reactions, further investigations into their specificity and biochemistry seem warranted.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352940      PMCID: PMC421556          DOI: 10.1128/iai.20.1.88-98.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The immune response to polysaccharides from yeast-like fungi in sensitized experimental animals.

Authors:  N P Elinov; M A Kashkina; A P Kashkin; V P Iljina
Journal:  Mykosen       Date:  1975-10

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Glycohydrolase contamination of commercial enzymes frequently used in the preparation of fungal cell walls.

Authors:  T E Davis; J E Domer
Journal:  Anal Biochem       Date:  1977-06       Impact factor: 3.365

4.  Delayed-type hypersensitivity in the mouse. II. Transfer by thymus-derived (T) cells.

Authors:  M G Cooper
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

5.  Delayed hypersensitivity to fungal antigens in mice. I. Use of the intradermal skin and footpad swelling tests as assays of active and passive sensitization.

Authors:  D Rifkind; J A Frey; J R Davis; E A Petersen; M Dinowitz
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

6.  Delayed hypersensitivity in the mouse.

Authors:  A J Crowle
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  Lymphocyte stimulation in Candida albicans infections.

Authors:  A Frisk; L V von Stedingk; J Wasserman
Journal:  Sabouraudia       Date:  1974-03

8.  Skin reaction and macrophage migration inhibition tests for polysaccharides from Aspergillus fumigatus and Candida albicans.

Authors:  M Suzuki; Y Hayashi
Journal:  Jpn J Microbiol       Date:  1975-10

9.  In vivo and in virto cellular responses to cytoplasmic and cell wall antigens of Histoplasma capsulatum in artificially immunized or infected guinea pigs.

Authors:  J E Domer
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

10.  Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls.

Authors:  E Reiss; S H Stone; H F Hasenclever
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more
  24 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Immune responses to yeast and mycelial forms of Candida albicans in intraperitoneally infected mice.

Authors:  J Ponton; P Regulez; R Cisterna
Journal:  Mycopathologia       Date:  1986-04       Impact factor: 2.574

3.  Isolation and characterization of cell wall and cytoplasmic antigens and peripheral blood leukocyte responses in rabbits immunized with Candida albicans.

Authors:  Y E Shi
Journal:  Acta Acad Med Wuhan       Date:  1985

4.  Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice.

Authors:  E Balish; H Filutowicz; T D Oberley
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice.

Authors:  D K Giger; J E Domer; S A Moser; J T McQuitty
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.

Authors:  A A Gaspari; R Burns; A Nasir; D Ramirez; R K Barth; C G Haidaris
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans.

Authors:  C M Ausiello; F Urbani; S Gessani; G C Spagnoli; M J Gomez; A Cassone
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  S Mahanty; R A Greenfield; W A Joyce; P W Kincade
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.

Authors:  S A Moser; J E Domer; F J Mather
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

10.  Cellular and humoral immune responses to Candida albicans in subcutaneously infected mice.

Authors:  J Ponton; G Quindos; P Regulez; R Cisterna
Journal:  Mycopathologia       Date:  1985-10       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.